<![CDATA[Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma]]>

Summary: For a long time, doctors used strong chemotherapy to treat a blood cancer called advanced Hodgkin lymphoma. These older treatments helped patients, but they had tough side effects. Patients often suffered from nerve damage or dangerous infections.

Now, doctors are testing a newer, smarter treatment in a study called SWOG S1826. They are using a drug called nivolumab, which helps the immune system target the cancer cells directly. This new method is proving to be highly effective and causes much less collateral damage to the patient's body than the older drugs.

For more details, see cancernetwork at cancernetwork.com/view/outlining-common-drawbacks-to-prior-standards-for-hodgkin-lymphoma (opens in new tab)